CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. - Wikidata - awgldk - TriplyDB

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.

http://www.wikidata.org/entity/Q37145296

about

Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation Heterologous immunity between viruses Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.Saving lives by training innate immunity with bacille Calmette-Guerin vaccine.MHC basis of T cell-dependent heterologous immunity to arenaviruses.Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges.Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis.Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection Vaccination and heterologous immunity: educating the immune system Evaluation of non-reciprocal heterologous immunity between unrelated viruses Cross-reactivity of T cells and its role in the immune system MHV68 latency modulates the host immune response to influenza A virus.The two faces of heterologous immunity: protection or immunopathology.Trained immunity: consequences for the heterologous effects of BCG vaccination.BCG-associated heterologous immunity, a historical perspective: experimental models and immunological mechanisms.Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines.Polymorphism in liver-stage malaria vaccine candidate proteins: immune evasion and implications for vaccine design.Harnessing the power of genomics and immunoinformatics to produce improved vaccines.Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity.The generation of CD8+ T-cell population specific for vaccinia virus epitope involved in the antiviral protection against ectromelia virus challenge.Macrophages largely contribute to heterologous anti-Propionibacterium acnes antibody-mediated protection from Actinobacillus pleuropneumoniae infection in mice.Species neutral correlates of immunogenicity for vaccines and protein therapeutics: fact or science fiction Distant lymph nodes serve as pools of Th1 cells induced by neonatal BCG vaccination for the prevention of asthma in mice.An anti-Propionibacterium acnes antibody shows heterologous resistance to an Actinobacillus pleuropneumoniae infection independent of neutrophils in mice.National Immunization Campaigns with Oral Polio Vaccine Reduce All-Cause Mortality: A Natural Experiment within Seven Randomized Trials.Heterologous effects of infant BCG vaccination: potential mechanisms of immunity

P2860

Q26752289-63B66E12-4DDC-404C-B80F-3F3C5B095408 Q34051846-19A33306-F176-49B1-8AC3-46A1F223D8B5 Q34159981-C425C4C2-F7C7-4621-B945-2E54FD901D5D Q34306345-E1A98DB5-4EDB-4B38-8E09-2D9639C80E18 Q34337171-41CE3877-B9A1-4946-A7D4-5DE70F381D76 Q34439339-51295F43-D9E9-4F27-BE2A-A26DD3CAAF82 Q34464971-40A4C18A-8461-4385-8040-1D343E450816 Q35105666-6B11075B-7CBE-4056-8F7E-D0EDFB7B985C Q35152750-BC66E94D-F620-468C-8284-394D5EB72A38 Q35706798-6C82697A-4C5F-4F76-A335-5F420C4F22EF Q36678774-B0648B7D-8768-4918-B8F6-E1FAD2D803A8 Q37302071-B18A144F-8E3E-4A0C-A6BC-19B8DD06235E Q37581439-FD48CE1B-1485-4A2E-8F3C-053F62F87656 Q38312182-4302F24A-8642-4B48-9ABB-60E474532484 Q38312186-685C3E82-1CFE-41BA-9243-099E44F0C679 Q38543488-14E22CB2-DD68-404E-9D2B-64936EBC3D30 Q38648583-559FE987-658F-4856-8C7F-C3D77C9C4217 Q40162376-AA61FA0D-479D-4657-9D97-07B0EC1FEDB8 Q40828543-DB572AF9-328A-463B-8A67-646C984A782F Q40948671-65618B2A-23D6-46AB-AC83-CDC3D64091F2 Q41508403-70A18842-7938-46CB-A6BF-D36797902DBF Q42104952-9C119319-5D6E-4330-A552-F5BD4B27979B Q44361348-882D8ECD-281C-45BD-9C43-697DAD643B6E Q47767998-FDBEA95D-108E-4A41-95D4-C2B97E877824 Q49832015-386ED3E3-12A9-49E0-B281-4D61A5BB240F Q58767332-0E16BCC4-0B2F-4351-916E-1012CECB3185

P2860

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.

http://www.wikidata.org/entity/Q37145296

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.

@en

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.

@nl

type

label

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.

@en

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.

@nl

prefLabel

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.

@en

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.

@nl

P1433

Q37145296-5D13B59A-4232-4A0E-95E4-6EC007BEC140

P1476

Q37145296-A7CA1EAB-31B1-442B-B3C0-F440C1B346E8

P2093

Q37145296-314A90D0-0557-4C87-A1EF-B3E25A6D0E8D

Q37145296-591C7823-676F-4DB1-8499-7B6D2B7FC677

Q37145296-DFD1CA56-4BC2-44E3-B470-EECD85FCF9AE

Q37145296-E8A4A4A8-22D7-4790-B598-F50052D7D3FD

P2860

Q37145296-016C1ADB-971F-4EE5-BFDF-9F0688B6A575

Q37145296-0C02E348-E8E1-4B07-9C6F-A5216FD740C7

Q37145296-11E21426-8AB5-45F7-B649-B92B162951E6

Q37145296-1226D501-CBFB-4E73-B64B-29442C40A183

Q37145296-143ECABF-FDC2-4BDE-BC7F-BDBE88E8EBBE

Q37145296-15289757-62F1-4710-8048-1161767018C8

Q37145296-17FAC0B8-0B14-47CB-972C-AC532A0DE523

Q37145296-18784E41-D1C0-477D-A514-45352AD66281

Q37145296-18A119B5-4BB2-470E-B9A3-84FB38B8E0FF

Q37145296-1AD0F04B-C1EB-49B8-885E-BD3257CA6282

P304

Q37145296-481EFAA6-C6D1-41AE-B275-31DCC9C38BD7

P31

Q37145296-EF06A6B6-BD3B-45A9-A974-9BD50FCE9C1A

P356

Q37145296-3BC8B1A2-5B31-4DFA-82BD-9EF852C1B6A4

P407

Q37145296-852A0573-44D1-4E6A-9C45-BE2571F1B16D

P433

Q37145296-8827DB20-CF4B-47B6-8ED2-EF554E58352B

P478

Q37145296-1260F9DD-538B-41CC-8691-6A96D6A3D3E6

P577

Q37145296-C1AAED1A-5676-43B2-9FF5-0AFD34784C67

P698

Q37145296-11E5F283-5BCA-473E-AF84-E5CC4B94CCDB

P932

Q37145296-DF8B620F-EC91-48DB-A82D-831963DB96BE

P356

P1433

Journal of Virology

P1476

CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.

@en

P2093

Gregory W Martens

http://www.w3.org/2001/XMLSchema#string

Hardy Kornfeld

http://www.w3.org/2001/XMLSchema#string

Keisha S Mathurin

http://www.w3.org/2001/XMLSchema#string

Raymond M Welsh

http://www.w3.org/2001/XMLSchema#string

P2860

Functional role of type I and type II interferons in antiviral defense

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

Cross-reactivity between HLA-A2-restricted FLU-M1:58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individuals

Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells.

Heterologous T cell immunity in severe hepatitis C virus infection

Herpesvirus latency confers symbiotic protection from bacterial infection

Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever

Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.

No one is naive: the significance of heterologous T-cell immunity.

Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis

P304

3528-3539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02393-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19193795

http://www.w3.org/2001/XMLSchema#string

P932

2663272

http://www.w3.org/2001/XMLSchema#string